Publications

1. Tabaja H, Chesdachai S, Shah AS, Stevens RW, DeMartino RR, Erben YM, Wilson WR, Baddour LM, DeSimone DC. Executive Summary: State-of-the-Art Review: Fostering Collaborative Teamwork-A Comprehensive Approach to Vascular Graft Infection Following Arterial Reconstructive Surgery. Clin Infect Dis. 2024 Jun 14; 78 (6):1391-1392
   View PubMed
2. Tabaja H, Chesdachai S, Shah AS, Stevens RW, DeMartino RR, Erben YM, Wilson WR, Baddour LM, DeSimone DC. Fostering Collaborative Teamwork-A Comprehensive Approach to Vascular Graft Infection Following Arterial Reconstructive Surgery. Clin Infect Dis. 2024 Jun 14; 78 (6):e69-e80
   View PubMed
3. Haddad SF, Lahr BD, El Sabbagh A, Wilson WR, Chesdachai S, DeSimone DC, Baddour LM. Percutaneous mechanical aspiration in patients with right-sided infective endocarditis: An analysis of the national inpatient sample database-2016-2020. Catheter Cardiovasc Interv. 2024 Feb; 103 (3):464-471 Epub 2024 Jan 29
   View PubMed
4. Corsini Campioli C, O'Horo JC, Lahr BD, Wilson WR, DeSimone DC, Baddour LM, Van Gompel JJ, Sohail MR. Predictors of Treatment Failure in Patients With Pyogenic Brain Abscess. World Neurosurg X. 2022 Oct; 16:100134 Epub 2022 Aug 08
   View PubMed
5. Corsini Campioli C, Castillo Almeida NE, O'Horo JC, Wilson WR, Cano E, DeSimone DC, Baddour LM, Sohail MR. Diagnosis, management, and outcomes of brain abscess due to gram-negative versus gram-positive bacteria. Int J Infect Dis. 2022 Feb; 115:189-194 Epub 2021 Dec 12
   View PubMed
6. Corsini Campioli C, Challener D, Comba IY, Shah A, Wilson WR, Sohail MR, Van Gompel JJ, O'Horo JC. Overview and risk factors for postcraniotomy surgical site infection: A four-year experience. Antimicrob Steward Healthc Epidemiol. 2022; 2 (1):e14 Epub 2022 Jan 31
   View PubMed
7. Corsini Campioli C, Castillo Almeida NE, O'Horo JC, Esquer Garrigos Z, Wilson WR, Cano E, DeSimone DC, Baddour LM, Van Gompel JJ, Sohail MR. Bacterial Brain Abscess: An Outline for Diagnosis and Management. Am J Med. 2021 Oct; 134 (10):1210-1217.e2 Epub 2021 July 21
   View PubMed
8. George MP, Esquer Garrigos Z, Vijayvargiya P, Anavekar NS, Luis SA, Wilson WR, Baddour LM, Sohail MR. Discriminative Ability and Reliability of Transesophageal Echocardiography in Characterizing Cases of Cardiac Device Lead Vegetations Versus Noninfectious Echodensities. Clin Infect Dis. 2021 Jun 1; 72 (11):1938-1943
   View PubMed
9. Baddour LM, Shafiyi A, Lahr BD, Anavekar NS, Steckelberg JM, Wilson WR, Sohail MR, DeSimone DC. A Contemporary Population-Based Profile of Infective Endocarditis Using the Expanded Rochester Epidemiology Project. Mayo Clin Proc. 2021 Jun; 96 (6):1438-1445 Epub 2021 Mar 05
   View PubMed
10. Wilson WR, Gewitz M, Lockhart PB, Bolger AF, DeSimone DC, Kazi DS, Couper DJ, Beaton A, Kilmartin C, Miro JM, Sable C, Jackson MA, Baddour LM, American Heart Association Young Hearts Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; and the Council on Quality of Care and Outcomes Research. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. Circulation. 2021 May 18; 143 (20):e963-e978 Epub 2021 Apr 15
    View PubMed
11. Romero-Brufau S, Chopra A, Ryu AJ, Gel E, Raskar R, Kremers W, Anderson KS, Subramanian J, Krishnamurthy B, Singh A, Pasupathy K, Dong Y, O'Horo JC, Wilson WR, Mitchell O, Kingsley TC. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study. BMJ. 2021 May 12; 373:n1087.
    View PubMed
12. DeSimone DC, Lahr BD, Anavekar NS, Sohail MR, Tleyjeh IM, Wilson WR, Baddour LM. Temporal Trends of Infective Endocarditis in Olmsted County, Minnesota, Between 1970 and 2018: A Population-Based Analysis. Open Forum Infect Dis. 2021 Mar; 8 (3):ofab038 Epub 2021 Jan 27
    View PubMed
13. Razonable RR, Marshall WF 3rd, Stevens RW, Kumar S, Murad MH, Wilson WR. Rapid Appraisal System for COVID-19 Medical Information. Mayo Clin Proc. 2020 Sep; 95 (9S):S26-S28 Epub 2020 June 22
    View PubMed
14. Wagner T, Shweta F, Murugadoss K, Awasthi S, Venkatakrishnan AJ, Bade S, Puranik A, Kang M, Pickering BW, O'Horo JC, Bauer PR, Razonable RR, Vergidis P, Temesgen Z, Rizza S, Mahmood M, Wilson WR, Challener D, Anand P, Liebers M, Doctor Z, Silvert E, Solomon H, Anand A, Barve R, Gores G, Williams AW, Morice WG 2nd, Halamka J, Badley A, Soundararajan V. Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis. Elife. 2020 Jul 7; 9 Epub 2020 July 07
    View PubMed
15. Razonable RR, Marshall WF, Stevens RW, Kumar S, Murad MH, Wilson WR. Mayo Clinic strategies for COVID-19 rapid appraisal system for COVID-19 medical information Mayo Clinic Proceeding. 2020.
    
16. Shafiyi A, Anavekar NS, Virk A, Sohail MR, Lahr BD, DeSimone DC, Wilson WR, Baddour LM. Repeat transesophageal echocardiography in infective endocarditis: An analysis of contemporary utilization. Echocardiography. 2020 Jun; 37 (6):891-899 Epub 2020 May 16
    View PubMed
17. Shadrin IY, Albitar HAH, Paim AC, Issa M, Wilson WR. Migratory Polyarthralgias and Skin Rash: Rat Bite Fever with a Positive Anti-Cyclic Citrullinated Peptide. Mayo Clin Proc Innov Qual Outcomes. 2020 Apr; 4 (2):223-227 Epub 2020 Mar 09
    View PubMed
18. Virk A, Schutte KM, Steckelberg JM, Wilson WR, Sinak LJ, Baddour LM. End-of-Therapy Echocardiography May Not Be Needed in All in Patients With Endocarditis. Open Forum Infect Dis. 2020 Mar; 7 (3):ofaa069 Epub 2020 Feb 28
    View PubMed
19. Hasse B, Hannan MM, Keller PM, Maurer FP, Sommerstein R, Mertz D, Wagner D, Fernandez-Hidalgo N, Nomura J, Manfrin V, Bettex D, Hernandez Conte A, Durante-Mangoni E, Tang TH, Stuart RL, Lundgren J, Gordon S, Jarashow MC, Schreiber PW, Niemann S, Kohl TA, Daley CL, Stewardson AJ, Whitener CJ, Perkins K, Plachouras D, Lamagni T, Chand M, Freiberger T, Zweifel S, Sander P, Schulthess B, Scriven JE, Sax H, van Ingen J, Mestres CA, Diekema D, Brown-Elliott BA, Wallace RJ Jr, Baddour LM, Miro JM, Hoen B, Athan E, Bayer A, Barsic B, Corey GR, Chu VH, Durack DT, Fortes CQ, Fowler V, Hoen B, Krachmer AW, Durante-Magnoni E, Miro JM, Wilson WR, M. chimaera ISCVID Investigators and//ISCVID Executive Committee//Infectious Diseases Specialists//Hospital Epidemiologists//Microbiologists and Molecular Typing Specialists//Cardiac Surgeons/ Perfusionists/ Cardiologists//Ophthalmology//Anaesthesiologists//Public Health. International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass. J Hosp Infect. 2020 Feb; 104 (2):214-235 Epub 2019 Nov 09
    View PubMed
20. Jang SK, Castillo Almeida NE, Ambroz R, Wilson W. Varicella-Zoster Virus Vasculopathy Leading to Multi-Focal Stroke in an Immunocompromised Patient. Am J Med 2020 Jan; 133 (1):e3-e4 Epub 2019 July 26
    View PubMed
21. Esquer Garrigos Z, George MP, Vijayvargiya P, Tan EM, Farid S, Abu Saleh OM, Friedman PA, Steckelberg JM, DeSimone DC, Wilson WR, Baddour LM, Sohail MR. Clinical Presentation, Management, and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Gram-Negative Versus Gram-Positive Bacteria. Mayo Clin Proc. 2019 Jul; 94 (7):1268-1277 Epub 2019 Mar 17
    View PubMed
22. Chakraborty T, Scharf E, DeSimone D, El Rafei A, Brinjikji W, Baddour LM, Wilson W, Steckelberg JM, Fugate JE, Wijdicks EFM, Rabinstein AA. Variable Significance of Brain MRI Findings in Infective Endocarditis and Its Effect on Surgical Decisions. Mayo Clin Proc. 2019 Jun; 94 (6):1024-1032 Epub 2019 Mar 25
    View PubMed
23. Esquer Garrigos Z, George MP, Khalil S, Vijayvargiya P, Abu Saleh OM, Friedman PA, Steckelberg JM, DeSimone DC, Wilson WR, Baddour LM, Sohail MR. Predictors of Bloodstream Infection in Patients Presenting With Cardiovascular Implantable Electronic Device Pocket Infection. Open Forum Infect Dis. 2019 Apr; 6 (4):ofz084 Epub 2019 Feb 21
    View PubMed
24. Miranda WR, Connolly HM, Baddour LM, Goel K, Wilson WR, Greason KL, Rihal CS, Holmes DR, Nkomo VT, Oh JK, Pislaru SV. Infective endocarditis following transcatheter aortic valve replacement: Diagnostic yield of echocardiography and associated echo-Doppler findings. Int J Cardiol. 2018 Nov 15; 271:392-395
    View PubMed
25. El Rafei A, DeSimone DC, Narichania AD, Sohail MR, Vikram HR, Li Z, Steckelberg JM, Wilson WR, Baddour LM. Comparison of Dual beta-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis. J Infect. 2018 Nov; 77 (5):398-404 Epub 2018 June 30
    View PubMed
26. Sims JR, Anavekar NS, Chandrasekaran K, Steckelberg JM, Wilson WR, Gersh BJ, Baddour LM, DeSimone DC. Utility of cardiac computed tomography scanning in the diagnosis and pre-operative evaluation of patients with infective endocarditis. Int J Cardiovasc Imaging. 2018 Jul; 34 (7):1155-1163 Epub 2018 Feb 15
    View PubMed
27. Esquer Garrigos Z, George MP, Farid S, Abu Saleh OM, Vijayvargiya P, Mahmood M, Friedman PA, Steckelberg JM, DeSimone DC, Wilson WR, Baddour LM, Sohail MR. Diagnostic evaluation and management of culture-negative cardiovascular implantable electronic device infections. Pacing Clin Electrophysiol. 2018 May 31 [Epub ahead of print]
    View PubMed
28. Sims JR, Anavekar NS, Bhatia S, O'Horo JC, Geske JB, Chandrasekaran K, Wilson WR, Baddour LM, Gersh BJ, DeSimone DC. Clinical, Radiographic, and Microbiologic Features of Infective Endocarditis in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 Feb 15; 121 (4):480-484 Epub 2017 Nov 23
    View PubMed
29. Chakraborty T, Scharf E, Rabinstein AA, DeSimone D, El Rafei A, Brinjikji W, Baddour LM, Wijdicks E, Wilson W, Steckelberg JM, Fugate JE. Utility of Brain Magnetic Resonance Imaging in the Surgical Management of Infective Endocarditis. J Stroke Cerebrovasc Dis. 2017 Nov; 26 (11):2527-2535 Epub 2017 June 30
    View PubMed
30. Tan EM, Nagpal A, DeSimone DC, Anderson B, Linderbaum J, De Ziel T, Li Z, Sohail MR, Cha YM, Loomis E, Espinosa R, Friedman PA, Greason K, Schiller H, Virk A, Wilson WR, Steckelberg JM, Baddour LM. Impacts of a care process model and inpatient electrophysiology service on cardiovascular implantable electronic device infections: a preliminary evaluation. J Interv Card Electrophysiol. 2017 Oct; 50 (1):117-124 Epub 2017 Aug 26
    View PubMed
31. Tissot-Dupont H, Casalta JP, Gouriet F, Hubert S, Salaun E, Habib G, Fernandez-Gerlinger MP, Mainardi JL, Tattevin P, Revest M, Lucht F, Botelho-Nevers E, Gagneux-Brunon A, Snygg-Martin U, Chan KL, Bishara J, Vilacosta I, Olmos C, San Roman JA, Lopez J, Tornos P, Fernandez-Hidalgo N, Durante-Mangoni E, Utili R, Paul M, Baddour LM, DeSimone DC, Sohail MR, Steckelberg JM, Wilson WR, Raoult D. International experts' practice in the antibiotic therapy of infective endocarditis is not following the guidelines. Clin Microbiol Infect. 2017 Oct; 23 (10):736-739 Epub 2017 Mar 18
    View PubMed
32. Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, Seymour JF, Kelly K, Gribben J, Pfreunschuh M, Morschhauser F, Schoder H, Zelenetz AD, Rademaker J, Advani R, Valente N, Fortpied C, Witzig TE, Sehn LH, Engert A, Fisher RI, Zinzani PL, Federico M, Hutchings M, Bollard C, Trneny M, Elsayed YA, Tobinai K, Abramson JS, Fowler N, Goy A, Smith M, Ansell S, Kuruvilla J, Dreyling M, Thieblemont C, Little RF, Aurer I, Van Oers MHJ, Takeshita K, Gopal A, Rule S, de Vos S, Kloos I, Kaminski MS, Meignan M, Schwartz LH, Leonard JP, Schuster SJ, Seshan VE. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol. 2017 Jul 1; 28 (7):1436-1447
    View PubMed
33. Tan EM, DeSimone DC, Sohail MR, Baddour LM, Wilson WR, Steckelberg JM, Virk A. Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression. Clin Infect Dis. 2017 Jun 1; 64 (11):1516-1521
    View PubMed
34. DeSimone DC, El Rafei A, Challener DW, Carr AB, Kelly JA, Rocca WA, St Sauver JL, Bock-Goodner CM, Lahr BD, Steckelberg JM, Wilson WR, Baddour LM. Effect of the American Heart Association 2007 Guidelines on the Practice of Dental Prophylaxis for the Prevention of Infective Endocarditis in Olmsted County, Minnesota. Mayo Clin Proc. 2017 May 10 [Epub ahead of print]
    View PubMed
35. Mesa RA, Miller CB, Thyne M, Mangan J, Goldberger S, Fazal S, Ma X, Wilson W, Paranagama DC, Dubinski DG, Naim A, Parasuraman S, Boyle J, Mascarenhas JO. Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey. Cancer. 2017 Feb 1; 123 (3):449-458 Epub 2016 Sept 30
    View PubMed
36. Wilson WR, Bower TC, Creager MA, Amin-Hanjani S, O'Gara PT, Lockhart PB, Darouiche RO, Ramlawi B, Derdeyn CP, Bolger AF, Levison ME, Taubert KA, Baltimore RS, Baddour LM, American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; C. Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association. Circulation. 2016 Nov 15; 134 (20):e412-e460 Epub 2016 Oct 13
    View PubMed
37. Miranda WR, Connolly HM, Bonnichsen CR, DeSimone DC, Dearani JA, Maleszewski JJ, Greason KL, Wilson WR, Baddour LM. Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults. Eur Heart J Cardiovasc Imaging. 2016 Aug; 17 (8):936-43 Epub 2016 May 08
    View PubMed
38. El Rafei A, Desimone DC, Sohail MR, Desimone CV, Steckelberg JM, Wilson WR, Baddour LM. Cardiovascular Implantable Electronic Device Infections due to Propionibacterium Species. Pacing Clin Electrophysiol. 2016 Jun; 39 (6):522-30 Epub 2016 Apr 22
    View PubMed
39. Tande AJ, Palraj BR, Osmon DR, Berbari EF, Baddour LM, Lohse CM, Steckelberg JM, Wilson WR, Sohail MR. Clinical Presentation, Risk Factors, and Outcomes of Hematogenous Prosthetic Joint Infection in Patients with Staphylococcus aureus Bacteremia. Am J Med. 2016 Feb; 129 (2):221.e11-20 Epub 2015 Oct 08
    View PubMed
40. El Rafei A, DeSimone DC, DeSimone CV, Lahr BD, Steckelberg JM, Sohail MR, Wilson WR, Baddour LM. Beta-haemolytic streptococcal endocarditis: clinical presentation, management and outcomes. Infect Dis (Lond). 2016; 48: (5)373-8.
    View PubMed
41. Miranda WR, Connolly HM, DeSimone DC, Phillips SD, Wilson WR, Sohail MR, Steckelberg JM, Baddour LM. Infective Endocarditis Involving the Pulmonary Valve. Am J Cardiol. 2015 Dec 15; 116: (12)1928-31.
    View PubMed
42. DeSimone DC, Tleyjeh IM, Correa de Sa DD, Anavekar NS, Lahr BD, Sohail MR, Steckelberg JM, Wilson WR, Baddour LM. Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN. Am Heart J. 2015 Oct; 170 (4):830-6 Epub 2015 July 17
    View PubMed
43. Gupta A, Osmon DR, Hanssen AD, Lightner DJ, Wilson WR, Steckelberg JM, Baddour LM, Harmsen WS, Mandrekar JN, Berbari EF. Genitourinary Procedures as Risk Factors for Prosthetic Hip or Knee Infection: A Hospital-Based Prospective Case-Control Study. Open Forum Infect Dis. 2015 Sep; 2 (3):ofv097 Epub 2015 June 30
    View PubMed
44. DeSimone DC, DeSimone CV, Tleyjeh IM, Correa de Sa DD, Anavekar NS, Lahr BD, Sohail MR, Steckelberg JM, Wilson WR, Baddour LM. Association of Mitral Valve Prolapse With Infective Endocarditis Due to Viridans Group Streptococci. Clin Infect Dis. 2015 Aug 15; 61 (4):623-5 Epub 2015 May 11
    View PubMed
45. Palraj BR, Baddour LM, Hess EP, Steckelberg JM, Wilson WR, Lahr BD, Sohail MR. Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia. Clin Infect Dis. 2015 Jul 1; 61 (1):18-28 Epub 2015 Mar 25
    View PubMed
46. DeSimone DC, Tleyjeh IM, Correa de Sa DD, Anavekar NS, Lahr BD, Sohail MR, Steckelberg JM, Wilson WR, Baddour LM, Mayo Cardiovascular Infections Study Group. Incidence of Infective Endocarditis Due to Viridans Group Streptococci Before and After the 2007 American Heart Association's Prevention Guidelines: An Extended Evaluation of the Olmsted County, Minnesota, Population and Nationwide Inpatient Sample. Mayo Clin Proc. 2015 Jul; 90 (7):874-81
    View PubMed
47. Konopleva M, Thall PF, Yi CA, Borthakur G, Coveler A, Bueso-Ramos C, Benito J, Konoplev S, Gu Y, Ravandi F, Jabbour E, Faderl S, Thomas D, Cortes J, Kadia T, Kornblau S, Daver N, Pemmaraju N, Nguyen HQ, Feliu J, Lu H, Wei C, Wilson WR, Melink TJ, Gutheil JC, Andreeff M, Estey EH, Kantarjian H. Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia. Haematologica. 2015 Jul; 100 (7):927-34 Epub 2015 Feb 14
    View PubMed
48. Sohail MR, Palraj BR, Khalid S, Uslan DZ, Al-Saffar F, Friedman PA, Hayes DL, Lohse CM, Wilson WR, Steckelberg JM, Baddour LM. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol. 2015 Feb; 8 (1):137-44 Epub 2014 Dec 12
    View PubMed
49. Chintakuntlawar A, Kidd M, Al-Kali A, Wilson W, Thompson CA. Toxoplasmosis in patients with hematologic malignancies. Leuk Lymphoma 2015 Feb; 56 (2):536-8 Epub 2014 July 17
    View PubMed
50. Kebed KY, Bishu K, Al Adham RI, Baddour LM, Connolly HM, Sohail MR, Steckelberg JM, Wilson WR, Murad MH, Anavekar NS. Pregnancy and postpartum infective endocarditis: a systematic review. Mayo Clin Proc. 2014 Aug; 89 (8):1143-52 Epub 2014 July 01
    View PubMed
51. Vasoo S, Mason EL, Gustafson DR, Cunningham SA, Cole NC, Vetter EA, Steinmann SP, Wilson WR, Patel R, Berbari EF, Henry NK. Desulfovibrio legallii prosthetic shoulder joint infection and review of antimicrobial susceptibility and clinical characteristics of Desulfovibrio infections. J Clin Microbiol. 2014 Aug; 52 (8):3105-10 Epub 2014 May 21
    View PubMed
52. Hickson LJ, Gooden JY, Le KY, Baddour LM, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Sohail MR. Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients. Am J Kidney Dis. 2014 Jul; 64 (1):104-10 Epub 2014 Jan 03
    View PubMed
53. Habib A, Le KY, Baddour LM, Friedman PA, Hayes DL, Lohse CM, Wilson WR, Steckelberg JM, Sohail MR, Mayo Cardiovascular Infections Study Group. Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol. 2013 Mar 15; 111 (6):874-9 Epub 2012 Dec 29
    View PubMed
54. Coelho-Prabhu N, Oxentenko AS, Osmon DR, Baron TH, Hanssen AD, Wilson WR, Steckelberg JM, Baddour LM, Harmsen WS, Mandrekar J, Berbari EF. Increased risk of prosthetic joint infection associated with esophago-gastro-duodenoscopy with biopsy. Acta Orthop. 2013 Feb; 84 (1):82-6 Epub 2013 Jan 25
    View PubMed
55. Habib A, Irfan M, Baddour LM, Le KY, Anavekar NS, Lohse CM, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Sohail MR, Mayo Cardiovascular Infections Study Group . Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace. 2013 Feb; 15 (2):227-35 Epub 2012 Sept 05
    View PubMed
56. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR, Infectious Diseases Society of America. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013 Jan; 56 (1):1-10
    View PubMed
57. DeSimone DC, Baddour LM, Lahr BD, Chung HH, Wilson WR, Steckelberg JM, Mayo Cardiovascular Infections Study Group. Euthermic endocarditis. PLoS One. 2013; 8 (11):e80144 Epub 2013 Nov 11
    View PubMed
58. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR, Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013 Jan; 56 (1):e1-e25 Epub 2012 Dec 06
    View PubMed
59. Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM, Mayo Cardiovascular Infections Study Group. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardiol. 2012 Oct 15; 110(8):1143-9. Epub 2012 Jul 03.
    View PubMed
60. Baddour LM, Cha YM, Wilson WR. Clinical practice. Infections of cardiovascular implantable electronic devices. N Engl J Med. 2012 Aug 30; 367(9):842-9.
    View PubMed
61. Desimone DC, Tleyjeh IM, Correa de Sa DD, Anavekar NS, Lahr BD, Sohail MR, Steckelberg JM, Wilson WR, Baddour LM, Mayo Cardiovascular Infections Study Group. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines. Circulation. 2012 Jul 3; 126 (1):60-4 Epub 2012 June 11
    View PubMed
62. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, Taubert KA, Newburger JW, Gornik HL, Gewitz MH, Wilson WR, Smith SC Jr, Baddour LM, American Heart Association Rheumatic Fever Endocarditis and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young Council on Epidemiology and Prevention Council on Peripheral Vascular Disease and Council on Clinical Cardiolo. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012 May 22; 125(20):2520-44. Epub 2012 Apr 18
    View PubMed
63. Sohail MR, Hussain S, Le KY, Dib C, Lohse CM, Friedman PA, Hayes DL, Uslan DZ, Wilson WR, Steckelberg JM, Baddour LM. Erratum: Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections (Journal of Interventional Cardiac Electrophysiology (2011) 31:2 (171-183) DOI: 10.1007/s10840-010-9537-x) Journal of Interventional Cardiac Electrophysiology. 2012; 35 (3):355
    
64. Anavekar NS, Schultz JC, De Sa DD, Thomas JM, Lahr BD, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM. Modifiers of symptomatic embolic risk in infective endocarditis. Mayo Clin Proc. 2011 Nov; 86 (11):1068-74
    View PubMed
65. Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM, Mayo Cardiovascular Infections Study Group. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011 Nov; 8 (11):1678-85 Epub 2011 May 27
    View PubMed
66. Steckelberg RC, Wang AT, Wilson W. Infective endophthalmitis due to Group G Streptococcal infection in a patient with metastatic ovarian carcinoma. BMJ Case Rep. 2011 Aug 19; 2011
    View PubMed
67. Sohail MR, Hussain S, Le KY, Dib C, Lohse CM, Friedman PA, Hayes DL, Uslan DZ, Wilson WR, Steckelberg JM, Baddour LM, Mayo Cardiovascular Infections Study Group . Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol. 2011 Aug; 31 (2):171-83 Epub 2011 Mar 02
    View PubMed
68. Boland JM, Chung HH, Robberts FJ, Wilson WR, Steckelberg JM, Baddour LM, Miller DV. Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis. Mycoses. 2011 Jul; 54(4):354-60. Epub 2010 Apr 06.
    View PubMed
69. LE KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM, Mayo Cardiovascular Infections Study Group . Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol. 2011 Apr; 34 (4):450-9 Epub 2011 Jan 05
    View PubMed
70. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA 3rd, Gewitz M, Newburger JW, Schron EB, Taubert KA, American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Nursing, Council on Clinical Cardiology, Interdisciplinary Council on Quality of Care and Outcomes Research. A summary of the update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. J Am Dent Assoc. 2011 Feb; 142(2):159-65.
    View PubMed
71. Madhavan M, Sohail MR, Friedman PA, Hayes DL, Steckelberg JM, Wilson WR, Baddour LM, Mayo Cardiovascular Infections Study Group. Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus. Circ Arrhythm Electrophysiol. 2010 Dec; 3(6):639-45. Epub 2010 Sep 18.
    View PubMed
72. El Helou OC, Berbari EF, Lahr BD, Eckel-Passow JE, Razonable RR, Sia IG, Virk A, Walker RC, Steckelberg JM, Wilson WR, Hanssen AD, Osmon DR. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis. 2010 Aug; 29 (8):961-7 Epub 2010 May 27
    View PubMed
73. Shah NB, Suri RM, Melduni RM, Patel R, Kommedal O, Saebo O, Gustafson DR, Wilson WR, Baddour LM. Shuttleworthia satelles endocarditis: evidence of non-dental human disease. J Infect. 2010 Jun; 60(6):491-3. Epub 2010 Feb 17.
    View PubMed
74. Correa de Sa DD, Tleyjeh IM, Anavekar NS, Schultz JC, Thomas JM, Lahr BD, Bachuwar A, Pazdernik M, Steckelberg JM, Wilson WR, Baddour LM. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2010 May; 85 (5):422-6
    View PubMed
75. Uslan DZ, Dowsley TF, Sohail MR, Hayes DL, Friedman PA, Wilson WR, Steckelberg JM, Baddour LM. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol. 2010 Apr; 33(4):407-13. Epub 2009 Sep 30.
    View PubMed
76. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Montori VM, Hoskin TL, Enders F, Huskins WC, Mookadam F, Wilson WR, Zimmerman V, Baddour LM. Propensity score analysis with a time-dependent intervention is an acceptable although not an optimal analytical approach when treatment selection bias and survivor bias coexist. J Clin Epidemiol. 2010 Feb; 63(2):139-40. Epub 2009 Nov 12.
    View PubMed
77. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Montori VM, Hoskin TL, Enders F, Huskins WC, Mookadam F, Wilson WR, Zimmerman V, Baddour LM. Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. J Clin Epidemiol. 2010 Feb; 63(2):130-5.
    View PubMed
78. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA 3rd, Gewitz MH, Newburger JW, Schron EB, Taubert KA, American Heart Association Rheumatic Fever Endocarditis, Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young Council on Cardiovascular Surgery, Anesthesia, Council on Cardiovascular Nursing, Council on Clinical Cardiology, Interdisciplinary Council on Quality of Care, American Heart Assocation. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010 Jan 26; 121(3):458-77.
    
79. Noheria A, Anderson PW, Tapia-Zegarra GG, Baddour LM, Wilson WR. Infective endocarditis due to neisseria elongata. IDCP. 2010; 18(6):355-8.
    
80. Berbari EF, Osmon DR, Carr A, Hanssen AD, Baddour LM, Greene D, Kupp LI, Baughan LW, Harmsen WS, Mandrekar JN, Therneau TM, Steckelberg JM, Virk A, Wilson WR. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis. 2010 Jan 1; 50(1):8-16.
    View PubMed
81. Sia IG, Orillaza RB, St Sauver JL, Quelapio ID, Lahr BD, Alcaneses RS, Wilson WR, Cockerill FR, Balane GI, Mangubat NV, Wengenack NL, Tupasi TE. Tuberculosis attributed to household contacts in the Philippines. Int J Tuberc Lung Dis. 2010 Jan; 14 (1):122-5
    View PubMed
82. Fadel HJ, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM. Evaluation of antibiotic therapy following valve replacement for native valve endocarditis. Eur J Clin Microbiol Infect Dis. 2009 Nov; 28 (11):1395-8 Epub 2009 Aug 25
    View PubMed
83. Tleyjeh IM, Kashour T, Zimmerman V, Steckelberg JM, Wilson WR, Baddour LM. The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis. Am Heart J. 2008 Nov; 156(5):901-9. Epub 2008 Sep 11.
    View PubMed
84. Tleyjeh IM, Steckelberg JM, Georgescu G, Ghomrawi HM, Hoskin TL, Enders FB, Mookadam F, Huskins WC, Wilson WR, Baddour LM. The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis. Heart. 2008 Jul; 94(7):892-6. Epub 2008 Feb 28.
    View PubMed
85. Hoelzer BC, Weingarten TN, Hooten WM, Wright RS, Wilson WR, Wilson PR. Paraspinal abscess complicated by endocarditis following a facet joint injection. Eur J Pain. 2008 Apr; 12 (3):261-5 Epub 2007 July 02
    View PubMed
86. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Jenkins SM, Baddour LM. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008 Jan; 83(1):46-53.
    View PubMed
87. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT, American Heart Association. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2008 Jan; 139 Suppl:3S-24S.
    View PubMed
88. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee//American Heart Association Council on Cardiovascular Disease in the Young//American Heart Association Council on Clinical Cardiology//American Heart Association Council on Cardiovascular Surgery and Anesthesi. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007 Oct 9; 116 (15):1736-54 Epub 2007 Apr 19
    View PubMed
89. Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, Wilson WR, Baddour LM. A systematic review of population-based studies of infective endocarditis. Chest. 2007 Sep; 132 (3):1025-35
    View PubMed
90. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner SM, Baddour LM. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007 Jul 15; 45(2):166-73. Epub 2007 Jun 06.
    View PubMed
91. Knoll B, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM. Infective endocarditis due to penicillin-resistant viridans group streptococci. Clin Infect Dis. 2007 Jun 15; 44(12):1585-92.
    View PubMed
92. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT, American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young//Council on Clinical Cardiology//Council on Cardiovascular Surgery and Anesthesia//Quality of Care and Outcomes Research Interdisciplinary Working Group//American. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007 Jun; 138 (6):739-45, 747-60
    View PubMed
93. Levy MJ, Norton ID, Clain JE, Enders FB, Gleeson F, Limburg PJ, Nelson H, Rajan E, Topazian MD, Wang KK, Wiersema MJ, Wilson WR. Prospective Study of Bacteremia and Complications With EUS FNA of Rectal and Perirectal Lesions. Clin Gastroenterol Hepatol. 2007 Jun; 5(6):684-9.
    View PubMed
94. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner S, Baddour LM. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007 May 8; 49 (18):1851-9 Epub 2007 Apr 23
    View PubMed
95. Tleyjeh IM, Anavekar NS, Mirzoyev Z, Steckelberg JM, Haddad C, Khandaker MH, Wilson WR, Chandrasekaran K, Baddour LM. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis. 2007 May 1; 44 (9):1180-6 Epub 2007 Mar 14
    View PubMed
96. Moreillon P, Wilson WR, Leclercq R, Entenza JM. Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother. 2007 May; 51(5):1661-5. Epub 2007 Mar 12.
    View PubMed
97. Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR 3rd, St Sauver JL, Wilson WR, Baddour LM. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med. 2007 Apr 23; 167 (8):834-9
    View PubMed
98. Uslan DZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM, Wilson WR, Steckelberg JM, Baddour LM. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007 Apr 09; 167(7):669-75.
    View PubMed
99. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, Enders F, Moustafa S, Mookadam F, Huskins WC, Wilson WR, Baddour LM. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007 Apr 3; 115 (13):1721-8 Epub 2007 Mar 19
    View PubMed
100. Cooper LT Jr, Mensah GA, Baddour LM, Dunbar SB, Kaplan EL, Wilson WR, Shah PK. ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases. J Am Coll Cardiol. 2007 Mar 27; 49(12):1398-406.
     View PubMed
101. Cooper LT Jr, Mensah GA, Baddour LM, Dunbar SB, Kaplan EL, Wilson WR, Shah PK. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases. Circulation. 2007 Mar 27; 115(12):1681-9.
     View PubMed
102. Mensah GA, Grant AO, Pepine CJ, Baddour LM, Cooper LT Jr, Dunbar SB, Froelicher ES, Greenlund KJ, Kaplan EL, Kloner RA, Labarthe DR, Luepker RV, Madjid M, Muller JE, O'Connor S, Ornato JP, Robertson RM, Roy MJ, Shah PK, Taubert KA, Wilson WR, Zheng ZJ, Harrington RA, Abrams J, Anderson JL, Bates ER, Eisenberg MJ, Grines CL, Hlatky MA, Lichtenberg RC, Lindner JR, Pohost GM, Schofield RS, Shubrooks SJ Jr, Stein JH, Tracy CM, Vogel RA, Wesley DJ. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. Circulation. 2007 Mar 27; 115(12):1656-95. Epub 2007 Mar 19.
     View PubMed
103. Mensah GA, Grant AO, Pepine CJ, Baddour LM, Cooper LT Jr, Dunbar SB, Froelicher ES, Greenlund KJ, Kaplan EL, Kloner RA, Labarthe DR, Luepker RV, Madjid M, Muller JE, O'Connor S, Ornato JP, Robertson RM, Roy MJ, Shah PK, Taubert KA, Wilson WR, Zheng ZJ, Harrington RA, Abrams J, Anderson JL, Bates ER, Eisenberg MJ, Grines CL, Hlatky MA, Lichtenberg RC, Lindner JR, Pohost GM, Schofield RS, Shubrooks SJ Jr, Stein JH, Tracy CM, Vogel RA, Wesley DJ. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. J Am Coll Cardiol. 2007 Mar 27; 49(12):1373-412.
     View PubMed
104. Uslan DZ, Sohail MR, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis. 2006 Sep 15; 43(6):731-6. Epub 2006 Aug 04.
     View PubMed
105. Antonios VS, Noel AA, Steckelberg JM, Wilson WR, Mandrekar JN, Harmsen WS, Baddour LM. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect. 2006 Jul; 53(1):49-55. Epub 2005 Nov 28.
     View PubMed
106. Liang KP, Tleyjeh IM, Wilson WR, Roberts GD, Temesgen Z. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans. J Clin Microbiol. 2006 Mar; 44 (3):892-8
     View PubMed
107. Sohail MR, Martin KR, Wilson WR, Baddour LM, Harmsen WS, Steckelberg JM. Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med. 2006 Feb; 119(2):147-54.
     
108. Sohail MR, Khan AH, Holmes DR Jr, Wilson WR, Steckelberg JM, Baddour LM. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc. 2005 Aug; 80(8):1011-5.
     View PubMed
109. Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HM, Mirzoyev Z, Moustafa SE, Hoskin TL, Mandrekar JN, Wilson WR, Baddour LM. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA. 2005 Jun 22; 293 (24):3022-8
     View PubMed
110. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA, Committee on Rheumatic Fever Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, Councils on Clinical Cardiology Stroke and Cardiovascular Surgery and Anesthesia, American Heart Association, Infectious Diseases Society of America. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005 Jun 14; 111(23):e394-434.
     View PubMed
111. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever Endocarditis and Kawasaki Disease Council on Cardiovascular Disease in the Young American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004 Dec; 114(6):1708-33.
     View PubMed
112. Prabhu RM, Piper KE, Baddour LM, Steckelberg JM, Wilson WR, Patel R. Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. Antimicrob Agents Chemother. 2004 Nov; 48 (11):4463-5
     View PubMed
113. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004 Oct 26; 110(17):2747-71.
     View PubMed
114. Cockerill FR 3rd, Wilson JW, Vetter EA, Goodman KM, Torgerson CA, Harmsen WS, Schleck CD, Ilstrup DM, Washington JA 2nd, Wilson WR. Optimal testing parameters for blood cultures. Clin Infect Dis. 2004 Jun 15; 38 (12):1724-30 Epub 2004 May 25
     View PubMed
115. Issa NC, Rouse MS, Piper KE, Wilson WR, Steckelberg JM, Patel R. In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria. Diagn Microbiol Infect Dis. 2004 Jan; 48(1):73-5.
     View PubMed
116. Razonable RR, Rahman AE, Wilson WR. Lemierre syndrome variant: necrobacillosis associated with inferior vena cava thrombosis and pulmonary abscesses after trauma-induced leg abscess. Mayo Clin Proc. 2003 Sep; 78 (9):1153-6
     View PubMed
117. Levy MJ, Norton ID, Wiersema MJ, Schwartz DA, Clain JE, Vazquez-Sequeiros E, Wilson WR, Zinsmeister AR, Jondal ML. Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS-guided FNA. Gastrointest Endosc. 2003 May; 57: (6)672-8.
     View PubMed
118. Nicholson SC, Webb CD, Andriole VT, Jones RN, Wilson WR. Haemophilus influenzae in respiratory tract infections in community-based clinical practice: therapy with gatifloxacin. Diagnostic Microbiology & Infectious Disease. 2002 Sep; 44(1):101-7.
     View PubMed
119. Nicholson SC, Wilson WR, Naughton BJ, Gothelf S, Webb CD. Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumonia. Diagnostic Microbiology & Infectious Disease. 2002 Sep; 44(1):117-25.
     View PubMed
120. Piper KE, Rouse MS, Ronningen KL, Steckelberg JM, Wilson WR, Patel R. Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis. Antimicrob Agents Chemother. 2000 Sep; 44 (9):2554-6
     View PubMed
121. Patel R, Rouse MS, Florez MV, Piper KE, Cockerill FR, Wilson WR, Steckelberg JM. Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitis. J Infect Dis. 2000 Jan; 181(1):230-4.
     View PubMed
122. Piper KE, Rouse MS, Steckelberg JM, Wilson WR, Patel R. Ketolide treatment of Haemophilus influenzae experimental pneumonia. Antimicrob Agents Chemother. 1999 Mar; 43 (3):708-10
     View PubMed
123. Berbari EF, Jabre J, Lteif AN, Osmon DR, Wilson WR. Demographic characteristics of Lebanese medical graduates in the United States. Lebanese Order of Physicians Journal. 1999; 6:52-60.
     
124. Sexton DJ, Tenenbaum MJ, Wilson WR, Steckelberg JM, Tice AD, Gilbert D, Dismukes W, Drew RH, Durack DT. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Clin Infect Dis. 1998 Dec; 27(6):1470-1474.
     View PubMed
125. Jones RN, Wilson WR. Epidemiology, laboratory detection, and therapy of penicillin-resistant streptococcal infections. Diagnostic Microbiology & Infectious Disease. 1998 Jul; 31(3):453-9.
     View PubMed
126. Wilson WR. The role of fourth-generation cephalosporins in the treatment of serious infectious diseases in hospitalized patients. Diagn Microbiol Infect Dis. 1998 Jul; 31 (3):473-7
     View PubMed
127. Cockerill FR 3rd, Thompson RL, Musser JM, Schlievert PM, Talbot J, Holley KE, Harmsen WS, Ilstrup DM, Kohner PC, Kim MH, Frankfort B, Manahan JM, Steckelberg JM, Roberson F, Wilson WR. Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. Clin Infect Dis. 1998 Jun; 26 (6):1448-58
     View PubMed
128. Adde M, Shad A, Venzon D, Arndt C, Gootenberg J, Neely J, Nieder M, Owen W, Seibel N, Wilson W, Horak ID, Magrath I. Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas. Semin Oncol. 1998 Apr; 25(2 Suppl 4):33-9; discussion 45-8.
     View PubMed
129. Wilson WR. Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci, and other streptococci. Clin Microbiol Infect. 1998; 4 Suppl 3:S17-S26
     View PubMed
130. Bayer AS, Bolger AF, Taubert KA, Wilson WR, Steckelberg JM, Karchmer AW, Levison M, Chambers HINDFOOT, Dajani AS, Gewitz MH, Newburger JW, Gerber MA, Shulman ST, Pallasch TJ, Gage TW, Ferrieri P. Diagnosis and management of infective endocarditis and its complications Circulation. 1998; 98:2936-48.
     View PubMed
131. Miro JM, Wilson WR. Infectious complications of intravenous drug abuse. PP 11-20 in: Atlas of Infectious Diseases OM Korzeniowski ed, Churchill Livingston, Philadelphia,. 1998;
     
132. Rouse MS, Steckelberg JM, Brandt CM, Patel R, Miro JM, Wilson WR. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. Antimicrob Agents Chemother. 1997 Aug; 41 (8):1673-6
     View PubMed
133. Wilson WR, Bouza E, Lode H, Mouton Y. The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations. J Chemother. 1997 May; 9 Suppl 2:5-18.
     View PubMed
134. Cockerill FR 3rd, Hughes JG, Vetter EA, Mueller RA, Weaver AL, Ilstrup DM, Rosenblatt JE, Wilson WR. Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. Clin Infect Dis. 1997 Mar; 24 (3):403-18
     View PubMed
135. Das M, Badley AD, Cockerill FR, Steckelberg JM, Wilson WR. Infective endocarditis caused by HACEK microorganisms. Annu Rev Med. 1997; 48:25-33.
     View PubMed
136. Zuccaro G Jr, Wilson WR, Bayer AS. Antibiotic prophylaxis for bacterial endocarditis: an evolving story with new paradigms Arch Intern Med. 1997; 157:130-3.
     View PubMed
137. Dajani AS, Taubert KA, Wilson WR, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G. Prevention of bacterial endocarditis: recommendations by the American Heart Association JAMA. 1997; 277:1794-801.
     View PubMed
138. Garau J, Wilson WR, Wood Martin CJ. Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility Clin Microbiol Infect. 1997; 3(suppl 1):S87-S101.
     View PubMed
139. Caron F, Brandt CM, Rouse M, Laue N, Stratton CW, Wilson WR, Steckelberg JM. Importance of using relapse studies of tests for detection of antibiotic resistance before considering that a treatment for multidrug-resistant enterococcal experimental endocarditis is effective. J Infect Dis. 1997; 175(1):232-233.
     View PubMed
140. Cockerill FR 3rd, MacDonald KL, Thompson RL, Roberson F, Kohner PC, Besser-Wiek J, Manahan JM, Musser JM, Schlievert PM, Talbot J, Frankfort B, Steckelberg JM, Wilson WR, Osterholm MT. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA. 1997 Jan 1; 277 (1):38-43
     View PubMed
141. Brandt CM, Warner CB, Rouse MS, Steckelberg JM, Wilson WR. Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci. Antimicrob Agents Chemother. 1996 Dec; 40 (12):2901-3
     View PubMed
142. Patel R, Osmon DR, Steckelberg JM, Dekutoski MB, Wilson WR. Vertebral osteomyelitis due to Shigella boydii. Clin Infect Dis. 1996 May; 22 (5):863-4
     View PubMed
143. Brandt CM, Rouse MS, Laue NW, Stratton CW, Wilson WR, Steckelberg JM. Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis. 1996 Apr; 173 (4):909-13
     View PubMed
144. Cockerill FR 3rd, Williams DE, Eisenach KD, Williams DE, Kline BC, Miller LK, Stockman L, Voyles J, Caron GM, Bundy SK, Roberts GD, Wilson WR, Whelen AC, Hunt JM Jr, Persing DH. Prospective evaluation of the utility of molecular techniques for diagnosing nosocomial transmission of multidrug-resistant tuberculosis. Mayo Clin Proc. 1996 Mar; 71 (3):221-9
     View PubMed
145. Pechere JC, Wilson W, Neu H. Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporins. J Antimicrob Chemother. 1995 Nov; 36(5):757-71.
     View PubMed
146. MacMorran WS, Badley AD, Wilson WR. 26-year-old man with HIV infection and abdominal pain. Mayo Clin Proc. 1995 Sep; 70(9):885-8.
     View PubMed
147. Brandt CM, Rouse MS, Tallan BM, Laue NW, Wilson WR, Steckelberg JM. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis. Antimicrob Agents Chemother. 1995 Aug; 39 (8):1815-9
     View PubMed
148. Wilson WR. Selection of cephalosporins for hospital formularies. Diagn Microbiol Infect Dis. 1995 May-Jun; 22 (1-2):129-34
     View PubMed
149. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S, Bayer A, Bolger A, Gewitz M, Hutto C, Newburger J, Nouri S, Wilson WR. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals Pediatr. 1995; 96:758-64.
     
150. Wilson WR, Karchmer AW, Bisno AL, Dajani AS, Taubert KA, Bayer A, Kaye D, Ferrieri P, Shulman ST, Durack DT. Antibiotic treatment of adults with infective endocarditis due to viridans streptococci, enterococci, other streptococci, staphylococci, and HACEK microorgansims JAMA. 1995; 274:1706-13.
     View PubMed
151. Steele RW, Wilson WR. Challenges in the management of upper respiratory tract infection. Infect Med. 1995; 12(suppl):26-32.
     
152. Brandt CM, Rouse MS, Tallan BM, Wilson WR, Steckelberg JM. Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus. Antimicrob Agents Chemother. 1994 Sep; 38 (9):2191-3
     View PubMed
153. Wilson WR. Tolerance and safety of orally administered antimicrobial agents--an important factor in the selection of drug therapy. Curr Ther Res Clin Exp. 1994; 55(Suppl A):49-56.
     
154. Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed M, Ferieri P, Gerber M, Shulman ST, Karchmer AW, Wilson WR, Peter G, Durack DT, Rahimtoola S. Guidelines for long-term management of patients with Kawasaki Disease Circulation. 1994; 89:916-22.
     View PubMed
155. Wilson WR. New advances in oral antibiotic therapy: efficacy, safety, and compliance. Proceedings to 4th WPCCID Supplement to JAMA Southeast Asia December , pp 34-305. 1994; 0: 0.
     
156. Wilson WR. Management of complications of infective endocarditis Proceedings to 4th WPCCID Supplement to JAMA Southeast Asia December , pp 176-179. 1994; 0: 0.
     
157. Wilson WR. Introduction. Curr Ther Res Clin Exp. 1994; 55(Suppl A):1.
     
158. Ang BS, Telenti A, King B, King B, Steckelberg JM, Wilson WR. Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clin Infect Dis. 1993 Oct; 17 (4):662-6
     View PubMed
159. Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin North Am. 1993 Mar; 7(1):9-19.
     View PubMed
160. Steckelberg JM, Rouse MS, Tallan BM, Osmon DR, Henry NK, Wilson WR. Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis. Antimicrob Agents Chemother. 1993 Mar; 37 (3):554-8
     View PubMed
161. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, Takahashi M, Bierman FZ, Karchmer AW, Wilson WR, Rahimtoola SH, Durack DT, Peter G. Diagnosis and therapy of Kawasaki Disease in Children Circulation. 1993; 87:1776-80.
     View PubMed
162. Henry NK, Steckelberg JM, Wilson WR. Historical profiles of Mayo. The clinical use of penicillin--revisited. Mayo Clin Proc. 1992 Dec; 67:1128.
     
163. Grubbs NC, Schultz HJ, Henry NK, Ilstrup DM, Muller SM, Wilson WR. Ciprofloxacin versus trimethoprim-sulfamethoxazole: treatment of community-acquired urinary tract infections in a prospective, controlled, double-blind comparison. Mayo Clin Proc. 1992 Dec; 67 (12):1163-8
     View PubMed
164. Wilson WR, Gilbert DN, Bisno AL, Freedman LR, Smith C, Drusano G, Kaye D. Evaluation of new anti-infective drugs for the treatment of infective endocarditis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992 Nov; 15 Suppl 1:S89-95
     View PubMed
165. Wilson WR, Mosimann F. Prophylaxis and treatment of infections complicating abdominal surgery. J Hosp Infect. 1992 Nov; 22 Suppl A:3-8
     View PubMed
166. Hellinger WC, Rouse MS, Rabadan PM, Henry NK, Steckelberg JM, Wilson WR. Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci. Antimicrob Agents Chemother. 1992 Jun; 36 (6):1272-5
     View PubMed
167. Wilson WR. Fluoroquinolone therapy. The Practice of Internal Medicine-1992. 1992 May 11-15; 243:
     
168. Rouse MS, Tallan BM, Henry NK, Steckelberg JM, Wilson WR. Animal models as predictors of outcome of therapy with broad spectrum cephalosporins. J Antimicrob Chemother. 1992 Apr; 29 Suppl A:39-45
     View PubMed
169. Wilson WR. Recognition and treatment of infective endocarditis. Heart Disease & Stroke. 1992 Mar-Apr; 1(2):64-7.
     View PubMed
170. Rouse MS, Tallan BM, Steckelberg JM, Henry NK, Wilson WR. Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits. Antimicrob Agents Chemother. 1992 Jan; 36 (1):56-8
     View PubMed
171. Wilson WR. Ceftriaxone therapy of penicillin-susceptible streptococcal endocarditis JAMA. 1992; 267:279-80.
     View PubMed
172. Bisno AL, Dismukes WE, Durack DT, Kaplan EL, Karchmer AU, Kaye D, Rahimtoola SH, Sande MA, Sanford JP, Watanakunakorn C, Wilson WR. Guidelines for the diagnosis of rheumatic fever. JAMA. 1992; 268:2069-73.
     View PubMed
173. Henry NK, Steckelberg JM, Wilson WR. The Clinical Use of Penicillin - Revisited. Mayo Clnic Proc. 1992; 67:1128.
     
174. Smilack JD, Wilson WR, Cockerill FR 3rd. Tetracyclines, chloramphenicol, erythromycin, clindamycin, and metronidazole. Mayo Clin Proc. 1991 Dec; 66 (12):1270-80
     View PubMed
175. Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol. 1991 Aug; 29 (8):1635-9
     View PubMed
176. Steckelberg JM, Khandheria BK, Anhalt JP, Ballard DJ, Seward JB, Click RL, Wilson WR. Prospective evaluation of the risk of bacteremia associated with transesophageal echocardiography. Circulation. 1991 Jul; 84 (1):177-80
     View PubMed
177. Dorsher CW, Rosenblatt JE, Wilson WR, Ilstrup DM. Anaerobic bacteremia: decreasing rate over a 15-year period. Rev Infect Dis. 1991 Jul-Aug; 13 (4):633-6
     View PubMed
178. Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, Giuliani ER, Wilson WR. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med. 1991 Apr 15; 114 (8):635-40
     View PubMed
179. Ormand JE, Talley NJ, Shorter RG, Conley CR, Carpenter HA, Fich A, Wilson WR, Phillips SF. Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci. 1991 Feb; 36 (2):142-5
     View PubMed
180. Wilson WR. Treatment of infections caused by anaerobes. J Chemother. 1991 Feb; 3 Suppl 2:7-11.
     View PubMed
181. Bayer AS, Hutter AM, Wilson WR. Current management of infective endocarditis Patient Care. 1991; 25:15-37.
     
182. Guess HA, Resseguie LJ, Melton LJ 3rd, Kurland LT, Melton LJ 3rd, Lydick EG, Aksamit AJ, Wilson WR. Factors predictive of seizures among intensive care unit patients with gram-negative infections. Epilepsia. 1990 Sep-Oct; 31 (5):567-73
     View PubMed
183. Wilson WR, Khan A, Laws ER Jr. Transseptal approaches for pituitary surgery. Laryngoscope. 1990 Aug; 100(8):817-9.
     View PubMed
184. Ormand JE, Talley NJ, Carpenter HA, Shorter RG, Conley CR, Wilson WR, DiMagno EP, Zinsmeister AR, Phillips SF. [14C]urea breath test for diagnosis of Helicobacter pylori. Dig Dis Sci. 1990 Jul; 35 (7):879-84
     View PubMed
185. Steckelberg JM, Melton LJ 3rd, Ilstrup DM, Rouse MS, Wilson WR. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med. 1990 Jun; 88 (6):582-8
     View PubMed
186. Rouse MS, Wilcox RM, Henry NK, Steckelberg JM, Wilson WR. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother. 1990 Feb; 34 (2):273-6
     View PubMed
187. Gerecht WB, Henry NK, Hoffman WW, Muller SM, LaRusso NF, Rosenblatt JE, Wilson WR. Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. Arch Intern Med. 1989 Jun; 149(6):1279-84.
     View PubMed
188. Steckelberg JM, Keating MR, Rouse MS, Wilson WR. Lack of extracellular slime effect on treatment outcome of Staphylococcus epidermidis experimental endocarditis. J Antimicrob Chemother. 1989 Jan; 23 (1):117-21
     View PubMed
189. Wilson WR, Gersh BJ. Infective endocarditis. Curr Opinion Cardiol. 1989; 4:423-7.
     
190. Paya CV, Wilson WR. Gram-negative infective endocarditis. Infect Dis Clin Microbiol. 1989; 7:8-11.
     
191. Wilson WR. Cardiac infections. Curr Opinion Infect Dis. 1989; 2:202-5.
     
192. Disno AL, Dismukes WE, Durack DT, Kaplan EL, Karchmer AW, Kaye D, Rahimotoola SH, Sande MA, Sanford JP, Watanakunakorn C, Wilson WR. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci JAMA. 1989; 261:1471-7.
     View PubMed
193. Carty G, Meland NB, Jong G, Wilson WR. Ruptured dissecting hepatic artery aneurysm: a rare cause of abdominal apoplexy. Vasc Surg. 1989; 23:327-312.
     
194. Busk MF, Rosenow EC 3rd, Wilson WR. Invasive procedures in the diagnosis of pneumonia. Semin Respir Infect. 1988 Jun; 3 (2):113-22
     View PubMed
195. Wilson WR, Gersh BJ. Infective endocarditis: experimental and clinical developments, antimicrobial therapy and management of complications. Curr Opinion Cardiol. 1988; 3:400-4.
     
196. Fernandez-Guerrero M, Rouse MS, Henry NK, Wilson WR. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1988; 32:747-51.
     View PubMed
197. Van Scoy RE, Wilson WR. Antimicrobial agents in adult patients with renal insufficiency: initial dosage and general recommendations. Mayo Clin Proc. 1987 Dec; 62 (12):1142-5
     View PubMed
198. Wilson WR, Cockerill FR 3rd. Tetracyclines, chloramphenicol, erythromycin, and clindamycin. Mayo Clin Proc. 1987 Oct; 62 (10):906-15
     View PubMed
199. Wilson WR. Antimicrobial therapy of streptococcal endocarditis. J Antimicrob Chemother. 1987 Sep; 20 Suppl A:147-59
     View PubMed
200. Musial CE, Wilson WR, Sinkeldam IR, Roberts GD. Recovery of Blastomyces dermatitidis from blood of a patient with disseminated blastomycosis. J Clin Microbiol. 1987 Aug; 25(8):1421-3.
     View PubMed
201. McConnell ME, Sarria-Cepeda S, Rouse MS, Henry NK, Wilson WR. Comparative in vitro activity of the new penem CGP 31608. Eur J Clin Microbiol. 1987 Jun; 6(3):313-5.
     View PubMed
202. Enzler MJ, Rouse MS, Henry NK, Geraci JE, Wilson WR. In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis. J Infect Dis. 1987 May; 155(5):954-8.
     View PubMed
203. Henry NK, Rouse MS, Whitesell AL, McConnell ME, Wilson WR. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. Am J Med. 1987 Apr 27; 82(4A):73-5.
     View PubMed
204. Fernandez-Guerrero M, Rouse MS, Henry NK, Geraci JE, Wilson WR. In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis. Antimicrobial Agents & Chemotherapy. 1987 Mar; 31(3):430-3.
     View PubMed
205. Enzler MJ, Wilson WR, Giuliani ER. Noninvasive detection of cardiac abscesses complicating infective endocarditis. American Journal of Noninvasive Cardiology. 1987 Mar-Apr; 1:109-119.
     
206. Wilson WR, Gersh BJ. Infective endocarditis: experimental and clinical developments. Curr Opinion Cardiol. 1987; 2:506-13.
     
207. Stratton CA, Aldridge KE, Barry AL, Reller LB, Sanders CC, Standiford HC, Wilson WR. Methods for determining bactericidal activity of antimicrobial agents. The National Committee for Clinical Laboratory Standards and 7(2)35-74. 1987; 7: (1)1-34.
     
208. Henry NK, Schultz HJ, Grubbs NC, Muller SM, Ilstrup DM, Wilson WR. Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women. J Antimicrob Chemother. 1986 Nov; 18 Suppl D:103-6.
     View PubMed
209. Henry NK, Wilson WR, Geraci JE. Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin. Antimicrobial Agents & Chemotherapy. 1986 Nov; 30(5):725-8.
     View PubMed
210. Backes RJ, Rouse MS, Henry NK, Geraci JE, Wilson WR. Activity of penicillin combined with an aminoglycoside against group B streptococci in vitro and in experimental endocarditis. J Antimicrob Chemother. 1986 Oct; 18(4):491-8.
     View PubMed
211. Southorn PA, Plevak DJ, Wright AJ, Wilson WR. Adverse effects of vancomycin administered in the perioperative period. Mayo Clin Proc. 1986 Sep; 61(9):721-4.
     View PubMed
212. Henry NK, Wilson WR, Roberts RB, Acar JF, Geraci JE. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci. Antimicrobial Agents & Chemotherapy. 1986 Sep; 30(3):465-7.
     View PubMed
213. Freidig EE, Wilson WR, Washington JA II, Mcclure SP, Banks PM. Clinical-Histologic-Microbiologic analysis of 419 lymph node biopsy specimens. Rev Infect Dis. 1986; 8:322-8.
     View PubMed
214. Griffin MR, Wilson WR, Edwards WD, O'Fallon WM, Kurland LT. Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. JAMA. 1985 Sep 6; 254(9):1199-202.
     View PubMed
215. Wilson WR, Cockerill FR 3rd, Rosenow EC 3rd. Pulmonary disease in the immunocompromised host (2). Mayo Clin Proc. 1985 Sep; 60(9):610-31.
     View PubMed
216. Travis LB, Roberts GD, Wilson WR. Clinical significance of Pseudallescheria boydii: a review of 10 years' experience. Mayo Clin Proc. 1985 Aug; 60(8):531-7.
     View PubMed
217. Cockerill FR III, Wilson WR, Carpenter HA, Smith TF, Rosenow ECI. Open lung biopsy in immunocompromised patients. Arch Intern Med. 1985 Aug; 145(8):1398-404.
     View PubMed
218. Rosenow EC III, Wilson WR, Cockerill FRI. Pulmonary disease in the immunocompromised host. (First of two parts). Mayo Clin Proc. 1985 Jul; 60:473-487.
     View PubMed
219. Wilson WR, Geraci JE. Treatment of streptococcal infective endocarditis. Am J Med. 1985 Jun 28; 78(6B):128-37.
     View PubMed
220. Washington JA 2nd, Wilson WR. Erythromycin: a microbial and clinical perspective after 30 years of clinical use (2). Mayo Clin Proc. 1985 Apr; 60(4):271-8.
     View PubMed
221. Backes RJ, Wilson WR, Geraci JE. Group B streptococcal infective endocarditis. Arch Intern Med. 1985 Apr; 145(4):693-6.
     View PubMed
222. Washington JA 2nd, Wilson WR. Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1). Mayo Clin Proc. 1985 Mar; 60(3):189-203.
     View PubMed
223. Gleaves CA, Smith TF, Wold AD, Wilson WR. Detection of viral and chlamydial antigens in open-lung biopsy specimens. Am J Clin Pathol. 1985 Mar; 83(3):371-4.
     View PubMed
224. Rosenow EC III, Cockerill FR III, Wilson WR. Pulmonary complications in the immunocompromised host. Curr Pulmonol. 1985; 6:181-231.
     
225. Libertin CR, Wilson WR, Roberts GD. Candida lusitaniae--an opportunistic pathogen. Diagn Microbiol Infect Dis. 1985 Jan; 3: (1)69-71.
     View PubMed
226. Wilson WR, Zak O, Sande MA. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals. J Infect Dis. 1985; 141:1028-33.
     
227. Pulliam L, Dall L, Inokuchi S, Wilson WR, Hadley WK, Mills J. Effects of exopolysaccharide production by viridans streptococci on penicillin therapy of experimental endocarditis. J Infect Dis. 1985; 151:153-6.
     View PubMed
228. Indrelie JA, Wilson WR, Matsumoto JY, Geraci JE, Washington JA 2nd. Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis. Antimicrobial Agents & Chemotherapy. 1984 Dec; 26(6):909-12.
     View PubMed
229. Morgan MA, Wilson WR, Neel HB 3rd, Roberts GD. Fungal sinusitis in healthy and immunocompromised individuals. Am J Clin Pathol. 1984 Nov; 82(5):597-601.
     View PubMed
230. Libertin CR, Woloschak GE, Wilson WR, Smith TF. Analysis of Pneumocystis carinii cysts with a fluorescence-activated cell sorter. J Clin Microbiol. 1984 Nov; 20: (5)877-80.
     View PubMed
231. Wilson WR, Wilkowske CJ, Wright AJ, Sande MA, Geraci JE. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med. 1984 Jun; 100(6):816-23.
     View PubMed
232. Wilson WR, Henry NK, Keys TF, Anhalt JP, Cockerill FR 3rd, Edson RS, Geraci JE, Hermans PE, Muller SM, Rosenblatt JE. Empiric therapy with moxalactam alone in patients with bacteremia. Mayo Clin Proc. 1984 May; 59(5):318-26.
     View PubMed
233. Pien FD, Wilson WR, Kunz K, Washington JA 2nd. Aerococcus viridans endocarditis. Mayo Clin Proc. 1984 Jan; 59(1):47-8.
     View PubMed
234. Mills J, Pulliam L, Dall L, Marzouk J, Wilson WR, Costerton J. Exopolysaccharide production by viridans streptococci in experimental endocarditis. Infect Immun. 1984; 43:359-67.
     View PubMed
235. Cockerill FR 3rd, Wilson WR, Van Scoy RE. Traveling toothpicks. Mayo Clin Proc. 1983 Sep; 58(9):613-6.
     View PubMed
236. Henry NK, McLimans CA, Wright AJ, Thompson RL, Wilson WR, Washington JA 2nd. Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube. J Clin Microbiol. 1983 May; 17(5):864-9.
     View PubMed
237. Van Scoy RE, Wilson WR. Antimicrobial agents in patients with renal insufficiency. Mayo Clin Proc. 1983 Apr; 58(4):246-8.
     View PubMed
238. Wilson WR, Cockerill FR 3rd. Tetracyclines, chloramphenicol, erythromycin, and clindamycin. Mayo Clin Proc. 1983 Feb; 58(2):92-8.
     View PubMed
239. Brandenburg RO, Giuliani ER, Wilson WR, Geraci JE. Infective endocarditis--a 25 year overview of diagnosis and therapy. J Am Coll Cardiol. 1983 Jan; 1(1):280-91.
     View PubMed
240. Wilson WR. Antimicrobial chemoprophylaxis. Med Clin North Am. 1983 Jan; 67(1):99-112.
     View PubMed
241. Wilson WR, Geraci JE. Antibiotic treatment of infective endocarditis. Annu Rev Med. 1983; 34:413-27.
     View PubMed
242. Estaben A, Wilson WR, Ruiz-Santana S, Fernandez-Segoviano F, Martinez-Cabruja R. Endocarditis caused by B. fragilis. Chest. 1983; 84:104-7.
     View PubMed
243. Wilson WR, Geraci JE. Cardiac valve replacement in patients with active infective endocarditis. HERZ. 1983; 8:332-43.
     View PubMed
244. Wright AJ, Wilson WR, Matsumoto JY, Washington JA 2nd, Geraci JE. Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis. Antimicrobial Agents & Chemotherapy. 1982 Dec; 22(6):972-5.
     View PubMed
245. Thomson RB Jr, Smith TF, Wilson WR. Comparison of two methods used to prepare smears of mouse lung tissue for detection of Pneumocystis carinii. J Clin Microbiol. 1982 Aug; 16(2):303-6.
     View PubMed
246. Wright AJ, Thompson RL, McLimans CA, Wilson WR, Washington JA 2nd. The antimicrobial removal device. A microbiological and clinical evaluation. Am J Clin Pathol. 1982 Aug; 78(2):173-7.
     View PubMed
247. Geraci JE, Wilson WR. Endocarditis due to gram-negative bacteria: report of 56 cases. Mayo Clin Proc. 1982 Mar; 57:145-148.
     View PubMed
248. Wilson WR, Danielson GK, Giuliani ER, Geraci JE. Prosthetic valve endocarditis. Mayo Clin Proc. 1982 Mar; 57(3):155-61.
     View PubMed
249. Wilson WR, Giuliani ER, Danielson GK, Geraci JE. Management of complications of infective endocarditis. Mayo Clin Proc. 1982 Mar; 57(3):162-70.
     View PubMed
250. Wilson WR, Giuliani ER, Geraci JE. Treatment of penicillin-sensitive streptococcal infective endocarditis. Mayo Clin Proc. 1982 Feb; 57(2):95-100.
     View PubMed
251. Wilson WR, Giuliani ER, Danielson GK, Geraci JE. General considerations in the diagnosis and treatment of infective endocarditis. Mayo Clin Proc. 1982 Feb; 57(2):81-5.
     View PubMed
252. Wright AJ, Wilson WR. Experimental animal endocarditis. Mayo Clin Proc. 1982 Jan; 57(1):10-4.
     View PubMed
253. Auckenthalher R, Wilson W, Wright A, Washington J, Durack D, Geraci J. Lack of in vivo and in vitro bactericidal activity of n-formimidoyl thenamycin against entercocci. Antimicrobial Agents and Chemotherapy. 1982; 22:448-52.
     
254. Wilson WR. Management of patients with infective endocarditis: a holistic approach. J Gerogia Baptist Medical Center. 1982; 1:24-7.
     
255. Golla JA, Larson LA, Anderson CF, Lucas AR, Wilson WR, Tomasi TB Jr. An immunological assessment of patients with anorexia nervosa. Am J Clin Nutr. 1981 Dec; 34(12):2756-62.
     View PubMed
256. Geraci JE, Wilson WR. Vancomycin therapy for infective endocarditis. Rev Infect Dis. 1981 Nov-Dec; (3 Suppl):S250-8.
     
257. Wilson WR, Thompson RL, Wilkowske CJ, Washington JA 2nd, Giuliani ER, Geraci JE. Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. JAMA. 1981 Jan 23-30; 245(4):360-3.
     View PubMed
258. Bisno AL, Dismukes WE, Durack DT, Kaplan EL, Karchmer AW, Kaye D, Sande MA, Sanford JP, Wilson WR. Treatment of infective endocarditis due to viridans streptococci. Circulation. 1981; 63:730-3.
     View PubMed
259. Wilson WR. Clinical brief: a new broad-spectrum cephalosporin. Mayo Clin Proc. 1981 Jan; 56:63.
     
260. Matsumoto JY, Wilson WR, Wright AJ, Geraci JE, Washington JA II. Synergy of penicillin and decreasing concentrations of aminoglycosides against enterococci from patients with infective endocarditis. Antimicrob Agents Chemother. 1980 Dec; 18:944-947.
     View PubMed
261. McKenna UG, Meadows JA 3rd, Brewer NS, Wilson WR, Perrault J. Toxic shock syndrome, a newly recognized disease entity. Report of 11 cases. Mayo Clin Proc. 1980 Nov; 55(11):663-72.
     View PubMed
262. Wilson WR, Nichols DR, Thompson RL, Giuliani ER, Geraci JE. Infective endocarditis: therapeutic considerations. Am Heart J. 1980 Nov; 100(5):689-704.
     View PubMed
263. Geraci JE, Wilson WR, Washington JA 2nd. Infective endocarditis caused by Actinobacillus actinomycetemcomitans: report of four cases. Mayo Clin Proc. 1980 Jul; 55(7):415-9.
     View PubMed
264. Geraci JE, Wilson WR, Thompson JH Jr. Visceral leishmaniasis (kala-azar) as a cause of fever of unknown origin. Mayo Clin Proc. 1980 Jul; 55(7):455-8.
     View PubMed
265. Karchmer AW, Archer GL, Dismukes WE, Sande MA, Johnson DW Jr, Wilson WR. Staphylococcus epidermidis prosthetic valve endocarditis. pp. 904-906 in: Proceedings of the 11th International Congress of Chemotherapy. Am Society for Microbiology, 1980.
     
266. Bourgault AM, Wilson WR, Washington JA 2nd. Antimicrobial susceptibilities of species of viridans streptococci. J Infect Dis. 1979 Sep; 140(3):316-21.
     View PubMed
267. Wilson WR, Danielson GK, Giuliani ER, Washington JA 2nd, Jaumin PM, Geraci JE. Cardiac valve replacement in congestive heart failure due to infective endocarditis. Mayo Clin Proc. 1979 Apr; 54(4):223-6.
     View PubMed
268. Wilson WR, Danielson GK, Giuliani ER, Washington JA II, Jaumin PM, Geraci JE. Valve replacement in patients with active infective endocarditis. Circulation. 1978 Oct; 58:585-588.
     View PubMed
269. Wilson WR, Geraci JE, Wilkowske CJ, Washington JA 2nd. Short-term intramuscular therapy with procaine penicillin plus streptomycin for infective endocarditis due to viridans streptococci. Circulation. 1978 Jun; 57(6):1158-61.
     View PubMed
270. Wilson WR, Geraci JE, Danielson GK, Thompson RL, Spittell JA Jr, Washington JR 2nd, Giuliani ER. Anticoagulant therapy and central nervous system complications in patients with prosthetic valve endocarditis. Circulation. 1978 May; 57(5):1004-7.
     View PubMed
271. Geraci JE, Greipp PR, Wilkowske CJ, Wilson WR, Washington JA 2nd. Cardiobacterium hominis endocarditis. Four cases with clinical and laboratory observations. Mayo Clin Proc. 1978 Jan; 53(1):49-53.
     View PubMed
272. Van Scoy RE, Wilson WR. Antimicrobial agents in patients with renal insufficiency. Mayo Clin Proc. 1977 Nov; 52(11):704-6.
     View PubMed
273. Wilson WR. Tetracyclines, chloramphenicol, erythromycin, and clindamycin. Mayo Clin Proc. 1977 Oct; 52(10):635-40.
     View PubMed
274. Geraci JE, Wilkowske CJ, Wilson WR, Washington JA 2nd. Haemophilus endocarditis. Report of 14 patients. Mayo Clin Proc. 1977 Apr; 52(4):209-15.
     View PubMed
275. Wilson WR, Ritts RE Jr, Hermans PE. Abnormal chemotaxis in patients with cutaneous anergy. Mayo Clin Proc. 1977 Mar; 52(3):196-201.
     View PubMed
276. Wilson WR, Van Scoy RE, Washington JA 2nd. Incidence of bacteremia in adults without infection. J Clin Microbiol. 1976 Aug; 2(2):94-5.
     View PubMed
277. Wilson WR, Hermans PE, Ritts RE Jr. Idiopathic late-onset immunoglobulin deficiency with functional T-cell deficiency. Arch Intern Med. 1976 Mar; 136:343-346.
     View PubMed
278. Molenaar DM, Palumbo PJ, Wilson WR, Ritts RE Jr. Leukocyte chemotaxis in diabetic patients and their first-degree relatives. Diabetes. 1976; 25:880-883.
     View PubMed
279. Wilson WR, Rosenblatt JE, Washington JA 2nd. Anaerobic bacteremia. Conn Med. 1975 Oct; 39(10):597-600.
     View PubMed
280. Wilson WR, Jaumin PM, Danielson GK, Giuliani ER, Washington JA II, Geraci JE. Prosthetic valve endocarditis. Ann Intern Med. 1975 Jun; 82(6):751-6.
     View PubMed
281. Wilson WR, Ritts RE Jr, Hermans PE. Abnormal chemotaxis in patients with cutaneous anergy (PCA). J Reticuloendothel Soc. 1975; 18:22A.
     
282. Wilson WR, Dolan CT, Washington JA 2nd, Brown AL Jr, Ritts RE Jr. Clinical significance of postmortem cultures. Archives of Pathology & Laboratory Medicine. 1972 Sep; 94(3):244-9.
     View PubMed
283. Wilson WR, Martin WJ, Wilkowske CJ, Washington JA 2nd. Anaerobic bacteremia. Mayo Clin Proc. 1972 Sep; 47(9):639-46.
     View PubMed